DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma,MCL (Mantle Cell Lymphoma),MZL (Marginal Zone Lymphoma) Epcoritamab Shows Lasting Remissions in R/R LBCL Patients Oct 04, 2023
Lymphoma,Other Cancers Understanding Older Patients With Cancer and Their Caregivers’ Decision-Making Preferences Oct 04, 2023
FL (Follicular Lymphoma),Lymphoma Tisagenlecleucel Proves Safe And Effective In Patients With R/R FL Sep 27, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma ITMTX Vs IVMTX For CNS Relapse In High-Risk DLBCL Sep 27, 2023
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma Epcoritamab + R2 Regimen Improves Outcomes In Patients With High‑Risk Follicular Lymphoma Sep 26, 2023
Lymphoma Liso‑Cel Shows High Response Rates With A Favorable Safety Profile In R/R FL Patients Sep 25, 2023